Travere Therapeutics, Inc. ($TVTX)
Filing Information
| Accession Number | 0001943192-26-000006 |
|---|---|
| Form Type | 4 |
| Filing Date | Sep 18, 2026 |
| Document | View SEC Filing |
Transactions
6
Total Shares
90,508
Total Value
$3,497,343.99
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CHIEF FINANCIAL OFFICER | Common Stock | โ | Sep 15, 2026 | Exercise/Conversion | 20,000 | $17.44 | $348,800.00 | 138,016 | Direct | โ | View Details | |
CHIEF FINANCIAL OFFICER | Common Stock | โ | Sep 15, 2026 | Sale | 27,473 | $62.00 | $1,703,240.83 | 110,543 | Direct | โ | View Details | |
CHIEF FINANCIAL OFFICER | Common Stock | โ | Sep 15, 2026 | Sale | 20,735 | $62.61 | $1,298,174.81 | 89,808 | Direct | โ | View Details | |
CHIEF FINANCIAL OFFICER | Common Stock | โ | Sep 15, 2026 | Sale | 1,900 | $63.69 | $121,004.35 | 87,908 | Direct | โ | View Details | |
CHIEF FINANCIAL OFFICER | Common Stock | โ | Sep 15, 2026 | Sale | 400 | $65.31 | $26,124.00 | 87,508 | Direct | โ | View Details | |
CHIEF FINANCIAL OFFICER | Employee stock option (right to buy) | Derivative | Sep 15, 2026 | Exercise/Conversion | 20,000 | $0.00 | $0.00 | 0 | Direct | โ | View Details |